B7-33
Awaiting review, BioHarmony verdict
Not yet scored. Queued for review; until then rely on the status and sources below.
What is B7-33?
B7-33 is a preclinical single-chain relaxin-family peptide agonist studied for selective antifibrotic signaling in animal models. Human safety and effectiveness have not been established.
Saved on this device only.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for B7-33 yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
US approvalInvestigational
CompoundingEligibility not established.
Primary sources
- A single-chain derivative of the relaxin hormone is a functionally selective agonist of RXFP1 PubMed / Science Translational Medicine,
Related peptides for longevity & cellular
- 6.6ThymulinThymulin (zinc-thymulin) is a chemically defined, zinc-dependent thymic nonapeptide hormone with deep classical immunology behind it but no modern human trial of the…
- 5.9ThymalinThymalin is a bovine-thymus peptide extract studied for immune restoration and aging.
- 5.7VilonVilon is the Lysine-Glutamic acid (KE) dipeptide from Vladimir Khavinson's bioregulator program, sold for immune restoration and anti-aging.
- 4.1FOX04-DRIFOXO4-DRI is a designed senolytic peptide that kills senescent cells by breaking the FOXO4 to p53 bond, famous for restoring fur and kidney function in aged mice per…
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.